glp-1 for menopause weight loss | Provider-Led GLP‑1 and Menopause: Mounjaro, Wegovy,
Description
Additionally, due to individual variability and differences in developmental stages, the response to the medication may differ from that observed in adults, making it difficult to extrapolate the results of short-term studies to long-term usage scenarios
Celsa C, Pennisi G, Tulone A, et al
Serious complications affect fewer than 1% of patients, but understanding your risk profile is essential for a successful journey
These rates were highly correlated with baseline BMI and included discontinuations for perceived excessive weight loss
And indeed not only safe, but in fact cardioprotective, based on the SELECT trial
